Search - tctmd.com

Displaying 181 - 200 of 230

Sort: Relevancy | Date

News Industry News

Acute Results of the CorPath PRECISE Trial for Robotic-Assisted PCI to be Presented at ACC 2012

March 22, 2012

News Industry News

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

February 14, 2012

News Industry News

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 17, 2012

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

November 10, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

Resolute stent showed positive 1-year results in patients with diabetes

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

November 09, 2011

News Industry News

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

November 09, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Industry News

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

November 08, 2011

News Industry News

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

November 08, 2011

Advertisement

Acute Results of the CorPath PRECISE Trial for Robotic-Assisted PCI to be Presented at ACC 2012

St. Jude Medical Initiates a Study to Evaluate the Economic Impact of FFR in Asia and Australia

Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Eurocor’s DIOR DEB shows remarkable performance in diabetics with coronary lesions

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

Resolute stent showed positive 1-year results in patients with diabetes

Low CV Event Rate Prompts Closure of Prasugrel Trial

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit the Most from Impella Support

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content